Design
Review
Authors
Loading...
May identify TF/PAR2 as therapeutic targets in atherosclerosis; leaves open clinical translation pending prospective trials.
Key points are not available for this paper at this time.
Marutsuka et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: